Innovating Works

TARGETSET

financed
Commercial feasibility of targeting the histone methyltransferase SETD8 in cance...
Commercial feasibility of targeting the histone methyltransferase SETD8 in cancer New chemical entities and biomarkers. Within our ERC CoG grant, RSHEALTH, our group has contributed to the to the preclinical development of chemical inhibitors of the ATR kinase as anticancer agents, that are now in clinical trials by several companies. During the co... see more
31/12/2022
FUNDACION SECTOR P...
150K€
Project Budget: 150K€

Project leader
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIO... No se ha especificado una descripción o un objeto social para esta compañía.
TRL 4-5 | 18M€
PARTICIPATION DEPralty Sin fecha límite de participación.
Financing granted El organismo H2020 notifico la concesión del proyecto The day 2022-12-31
ERC-2020-POC: Call for proposals for ERC Proof of... Scope:Objectives:
Cerrada does 5 years
0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.